Hygeia Healthcare Holdings Co., Limited disclosed a share repurchase conducted on 26 June 2026 under its existing mandate dated 27 June 2025.

Key details • Volume repurchased: 344,800 ordinary shares, representing 0.06% of the company’s issued share capital excluding treasury shares before the transaction. • Price range: HKD 8.66 to HKD 8.72 per share; volume-weighted average of HKD 8.70. • Total consideration: HKD 2.99 million. • Post-transaction share base: issued shares (ex-treasury) fell to 607.74 million, while treasury shares rose to 10.76 million. The aggregate number of shares in issue (including treasury stock) remained 618.50 million.

Progress against mandate • Authorised capacity: 61.85 million shares. • Cumulative repurchases to date: 10.76 million shares, or 1.74% of the company’s issued shares as at the mandate date. • Moratorium: The company is restricted from issuing new shares or disposing of treasury shares on-market until 26 July 2026, in line with Hong Kong Stock Exchange rules.

All repurchase procedures were executed on the Hong Kong Stock Exchange and confirmed to be in full compliance with the Main Board Listing Rules and relevant regulations.